MEDIPLEX: A Phase 1 Study of Durvalumab (D) Combined with Pexidartinib (P) in Patients (pts) with Advanced Pancreatic Ductal Adenocarcinoma (PDAC) and Colorectal Cancer (CRC).Philippe Alexandre Cassier,Gwenaelle Garin,Lauriane Eberst,Jean-Pierre Delord,Sylvie Chabaud,Catherine Terret,Laure Montane,Anne-Sophie Bidaux, Severine Laurent, Lise Jaubert,Celine Ferlay,Mathilde Bernardin,Severine Tabone-Eglinger,Laurence Gilles-Afchain,Christine Menetrier-Caux,Christophe Caux,Isabelle Treilleux,David Perol,Carlos Alberto Gomez-RocaJournal of clinical oncology（2019）引用 43|浏览87AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
